Galactomannan testing might be useful for early diagnosis of fusariosis

Diagnostic Microbiology and Infectious Disease

Volumn 72, Issue 4, 2012, Pages 367-369

  Mikulska, Małgorzata ^a   Furfaro, Elisa ^a   Del Bono, Valerio ^a   Gualandi, Francesca ^a   Raiola, Anna Maria ^a   Molinari, Maria Pia ^a   Gritti, Paola ^a   Sanguinetti, Maurizio ^b   Posteraro, Brunella ^b   Bacigalupo, Andrea ^a   Viscoli, Claudio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Beta d glucan; Diagnosis; Fusariosis; Fusarium; Galactomannan; Transplant

Indexed keywords

1,3 BETA GLUCANASE; CIPROFLOXACIN; FLUCONAZOLE; GALACTOMANNAN; MEROPENEM; VORICONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLOOD SAMPLING; BRAIN HEMORRHAGE; CASE REPORT; COMATOSE PATIENT; DEATH; EARLY DIAGNOSIS; FEMALE; FEVER; FUNGUS IDENTIFICATION; FUSARIOSIS; FUSARIUM MONILIFORME; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKEMIA RELAPSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SEPSIS;

ANTIFUNGAL AGENTS; BETA-GLUCANS; EARLY DIAGNOSIS; FATAL OUTCOME; FEMALE; FUSARIOSIS; FUSARIUM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MANNANS; MIDDLE AGED;

EID: 84858334620     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2011.12.009     Document Type: Article

References (18)

1. Boutati E.I., Anaissie E.J. Fusarium, A significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. Blood 1997, 90:999-1008.
2. Cummings J.R., Jamison G.R., Boudreaux J.W., Howles M.J., Walsh T.J., Hayden R.T. Cross-reactivity of non-Aspergillus fungal species in the Aspergillus galactomannan enzyme immunoassay. Diagn. Microbiol. Infect. Dis. 2007, 59:113-115.
3. Dignani M.C., Anaissie E. Human fusariosis. Clin. Microbiol. Infect. 2004, 10(Suppl 1):67-75.
4. Gupta S., Almyroudis N.G., Battiwalla M., Bambach B.J., McCarthy P.L., Proefrock A.D., Ball D., Paplham P., Varma A., Kwon-Chung J., Segal B.H. Successful treatment of disseminated fusariosis with posaconazole during neutropenia and subsequent allogeneic hematopoietic stem cell transplantation. Transpl. Infect. Dis. 2007, 9:156-160.
5. Jossi M., Ambrosioni J., Macedo-Vinas M., Garbino J. Invasive fusariosis with prolonged fungemia in a patient with acute lymphoblastic leukemia: case report and review of the literature. Int. J. Infect. Dis. 2010, 14:e354-e356.
6. Kamphuis H.J., De Ruiter G.A., Veeneman G.H., van Boom J.H., Rombouts F.M., Notermans S.H. Detection of Aspergillus and Penicillium extracellular polysaccharides (EPS) by ELISA: using antibodies raised against acid hydrolysed EPS. Antonie Van Leeuwenhoek 1992, 61:323-332.
7. Kappe R., Schulze-Berge A. New cause for false-positive results withthe Pastorex aspergillus antigen latex agglutination test. J. Clin. Microbiol. 1993, 31:2489-2490.
8. Latge J.P., Kobayashi H., Debeaupuis J.P., Diaquin M., Sarfati J., Wieruszeski J.M., Parra E., Bouchara J.P., Fournet B. Chemical and immunological characterization of the extracellular galactomannan of Aspergillus fumigatus. Infect. Immun. 1994, 62:5424-5433.
9. Mennink-Kersten M.A., Ruegebrink D., Verweij P.E. Pseudomonas aeruginosa as a cause of 1,3-beta-d-glucan assay reactivity. Clin. Infect. Dis. 2008, 46:1930-1931.
10. Miyazaki T., Naoi Y. Chemical structures of main extracellular polysaccharides of Alternaria solani and Fusarium solani. Studies on fungal polysaccharides. XVIII. Chem. Pharm. Bull. (Tokyo) 1975, 23:1752-1758.
11. Nucci M., Anaissie E. Fusarium infections in immunocompromised patients. Clin. Microbiol. Rev. 2007, 20:695-704.
12. Roiz M.P., Garcia M.S., Agüero J., Ruiz de Alegria C., Perez del Molino Bernal I.C., Martínez-Martínez L. Detection of galactomannan in serum and isolates of Fusarium species from patients with proven invasive Fusarium infection. Abstract P1952. 21st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2011, Milan, Italy.
13. Stynen D., Sarfati J., Goris A., Prevost M.C., Lesourd M., Kamphuis H., Darras V., Latge J.P. Rat monoclonal antibodies against Aspergillus galactomannan. Infect. Immun. 1992, 60:2237-2245.
14. Swanink C.M., Meis J.F., Rijs A.J., Donnelly J.P., Verweij P.E. Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillusgalactomannan. J. Clin. Microbiol. 1997, 35:257-260.
15. Tortorano A.M., Esposto M.C., Prigitano A., Grancini A., Ossi C., Cavanna C., Lo Cascio G. Cross-reactivity of Fusarium spp in the Aspergillus galactomannan enzyme linked immunosorbent assay. 5th Trends in Medical Mycology (TIMM) 2011, Valencia, Spain.
16. Vagace J.M., Sanz-Rodriguez C., Casado M.S., Alonso N., Garcia-Dominguez M., de la Llana F.G., Zarallo L., Fajardo M., Bajo R. Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report. BMC Infect. Dis. 2007, 7:40.
17. Viscoli C., Machetti M., Cappellano P., Bucci B., Bruzzi P., Van Lint M.T., Bacigalupo A. False-positive galactomannan Platelia Aspergillus test results for patients receiving piperacillin-tazobactam. Clin. Infect. Dis. 2004, 38:913-916.
18. Yoshida M., Obayashi T., Iwama A., Ito M., Tsunoda S., Suzuki T., Muroi K., Ohta M., Sakamoto S., Miura Y. Detection of plasma (1 -> 3)-beta-d-glucan in patients with Fusarium, Trichosporon, Saccharomyces and Acremonium fungaemias. J. Med. Vet. Mycol. 1997, 35:371-374.